5^th International Conference on
Palliative Care and Gerontology

Biography:

Prof. Fan, Chief Physician, Doctoral Supervisor. She has expertise in lung cancer, energy integration medicine research for a long time. She has accumulated rich clinical experience also formed a unique treatment system. She is currently the evaluation Expert of  National Natural Science Foundation of China,  Evaluation Expert of  Shanghai Science and Technology Commission projects, Chairman of Shanghai CDC Committee on Cancer Prevention and Treatment, Director of Institute for the development of Integrative Medicine, Director of Energy Medicine and Health research Institute of Shanghai Jiao Tong University, Director of Energy Metabolism and Health research Institute of Tongji University,  Vice Chairman of healthy lifestyle council of Sino-Russian friendship, peace and development committee under the Ministry of Foreign Affairs, and Director of healthy lifestyle research center. Won the "Chinese Medical Science and Technology Award", "China Hospital Science and Technology Innovation Award", China "Wuzhou Women's Science and Technology" Award, and Shanghai "Medical Technology" Award.

Abstract:

Overall survival (OS) of lung cancer varies greatly with individual patients in the global setting. Multiple factors may affect the prognosis. Different antibiotics have significant effects on the prognosis of lung cancer patients. The intestinal microbiome, nutritional status and inflammatory factors all have significant impact on OS of lung cancer patients.The main mechanisms are as follows.1.Immunomodulatory effects of intestinal lung axis microecology on NSCLC.2. Prognostic mechanisms of antibiotic therapy for advanced NSCLC.3.The value of biomarkers in predicting survival of advanced NSCLC patients4. Albumin-bound paclitaxel has a favorable effect on advanced NSCLC and improves the quality of life5.Advanced NSCLC patients with metabolic disease have a worse prognosis.